FindTrial
Sign In

Expanded Access for Repotrectinib

Status
AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT05926232
Enrollment
Unknown
Registered
2023-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is an expanded access designed to provide access to Repotrectinib for eligible participants.

Interventions

DRUGRepotrectinib

Repotrectinib

Sponsors

Bristol-Myers Squibb
Lead SponsorINDUSTRY

Eligibility

Inclusion criteria

\-

Exclusion criteria

\-

Contacts

Primary ContactBMS Study Connect Contact Center http://www.bmsstudyconnect.com
Clinical.Trials@bms.com855-907-3286
Backup ContactFirst line of the email MUST contain NCT # and Site #.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026